ABBV Filing
10-QFiling Date: May 8, 2026

AbbVie Inc. (ABBV) · Quarterly Report (10-Q) SEC Filing

abbv-20260331

descriptionView SEC Filing
ACC: 0001551152-26-000017open_in_new
Key Financial Metrics3M Mar'26 · 2026-03-31
Revenue$15.00B
Net Income$695.0M
Total Assets$136.46B
Stockholders' Equity$22.96B
Operating Cash Flow$3.83B

keid AI analysis is for reference only and does not constitute investment advice.